ArticleMolecular biology reports2026
Biological activity of serine-proline dipeptide to Enterobacteriaceae bacteria.
Article in Molecular biology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSome dipeptides function as bioactive substances to prevent the illness such as hypertension and dementia. However, almost no dipeptides are known to directly contribute to prevention of bacterial infection. METHODS AND
resultsWe examined the antibacterial activity of dipeptides to six species of Gram-negative bacteria and a Gram-positive bacterium by the colony-forming units measurement and found that serine-proline dipeptide acts as an antibacterial agent selective on Enterobacteriaceae bacteria. In the microscopic observation of purified peptidoglycan particles, serine-proline dipeptide selectively disrupted Gram-negative bacterium-type peptidoglycan particles. In the protein analysis, serine-proline dipeptide induced hypertrophy of the bacterial cell bodies of an Enterobacteriaceae bacterium Klebsiella pneumoniae and caused the leakage of proteins from the bacterial cells. On the contrary, proline-serine dipeptide had no influence on the survival of all bacterial species examined. Apart from this, serine-proline dipeptide turned out to elicit the antibacterial ability of an antibiotic polymyxin B to Enterobacteriaceae bacteria. Meanwhile, proline-serine dipeptide inhibited the antibacterial action of polymyxin B on Enterobacteriaceae bacteria. In the molecular dynamics calculation, serine-proline dipeptide molecules integrated around a polymyxin B molecule and retained the stretched conformation of polymyxin B molecule. Meanwhile, a proline-serine dipeptide molecule interacted with joint moiety between the ring and linear structures of polymyxin B molecule and retained the folded conformation of its molecule. In sum, active and inactive forms of polymyxin B on Enterobacteriaceae bacteria were suggested to take the stretched and folded conformations, respectively.
conclusionsSerine-proline dipeptide may be beneficial to prevention of Enterobacteriaceae bacterial infection.
Indexed as
Identifiers
42201425What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.